 |
PDBsum entry 3gpw
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
250 a.a.
|
 |
|
|
|
|
|
|
|
244 a.a.
|
 |
|
|
|
|
|
|
|
241 a.a.
|
 |
|
|
|
|
|
|
|
242 a.a.
|
 |
|
|
|
|
|
|
|
233 a.a.
|
 |
|
|
|
|
|
|
|
244 a.a.
|
 |
|
|
|
|
|
|
|
243 a.a.
|
 |
|
|
|
|
|
|
|
222 a.a.
|
 |
|
|
|
|
|
|
|
204 a.a.
|
 |
|
|
|
|
|
|
|
198 a.a.
|
 |
|
|
|
|
|
|
|
212 a.a.
|
 |
|
|
|
|
|
|
|
222 a.a.
|
 |
|
|
|
|
|
|
|
233 a.a.
|
 |
|
|
|
|
|
|
|
196 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the yeast 20s proteasome in complex with salinosporamide derivatives: irreversible inhibitor ligand
|
|
Structure:
|
 |
Proteasome component y7. Chain: a, o. Synonym: macropain subunit y7, proteinase ysce subunit 7, multicatalytic endopeptidase complex subunit y7. Proteasome component y13. Chain: b, p. Fragment: sequence database residues 2-245. Synonym: macropain subunit y13, proteinase ysce subunit 13, multicatalytic endopeptidase complex subunit y13.
|
|
Source:
|
 |
Saccharomyces cerevisiae. Yeast. Organism_taxid: 4932. Organism_taxid: 4932
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.230
|
R-free:
|
0.255
|
|
|
Authors:
|
 |
M.Groll,V.R.Macherla,R.R.Manam,K.A.M.Arthur,C.B.Potts
|
|
Key ref:
|
 |
M.Groll
et al.
(2009).
Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition.
J Med Chem,
52,
5420-5428.
PubMed id:
|
 |
|
Date:
|
 |
|
23-Mar-09
|
Release date:
|
15-Sep-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P23639
(PSA2_YEAST) -
Proteasome subunit alpha type-2 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
250 a.a.
250 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P23638
(PSA3_YEAST) -
Proteasome subunit alpha type-3 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
258 a.a.
244 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P40303
(PSA4_YEAST) -
Proteasome subunit alpha type-4 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
254 a.a.
241 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P32379
(PSA5_YEAST) -
Proteasome subunit alpha type-5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
260 a.a.
242 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P40302
(PSA6_YEAST) -
Proteasome subunit alpha type-6 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
234 a.a.
233 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P21242
(PSA7_YEAST) -
Probable proteasome subunit alpha type-7 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
288 a.a.
244 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P21243
(PSA1_YEAST) -
Proteasome subunit alpha type-1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
252 a.a.
243 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P25043
(PSB2_YEAST) -
Proteasome subunit beta type-2 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
261 a.a.
222 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P25451
(PSB3_YEAST) -
Proteasome subunit beta type-3 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
205 a.a.
204 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P22141
(PSB4_YEAST) -
Proteasome subunit beta type-4 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
198 a.a.
198 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P30656
(PSB5_YEAST) -
Proteasome subunit beta type-5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
287 a.a.
212 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P23724
(PSB6_YEAST) -
Proteasome subunit beta type-6 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
241 a.a.
222 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z, 1, 2:
E.C.3.4.25.1
- proteasome endopeptidase complex.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleavage at peptide bonds with very broad specificity.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
52:5420-5428
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition.
|
|
M.Groll,
K.A.McArthur,
V.R.Macherla,
R.R.Manam,
B.C.Potts.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Many marketed drugs contain fluorine, reflecting its ability to modulate a
variety of biological responses. The unique 20S proteasome inhibition profile of
fluorosalinosporamide compared to chlorinated anticancer agent salinosporamide A
(NPI-0052) is exemplary and relates to each halogen's leaving group potential.
Crystal structures of fluoro-, hydroxy-, and bromosalinosporamide in complex
with the yeast 20S proteasome core particle (CP) provide mechanistic insights
into ligand binding and leaving group elimination and the ability to fine-tune
the duration of proteasome inhibition. Fluorosalinosporamide/CP crystal
structures determined over time offer striking snapshots of the ligand trapped
with an intact fluoroethyl group in anticipation of fluoride elimination,
followed by complete nucleophilic displacement of fluoride to give the highly
stabilized cyclic ether found for salinosporamide A and bromosalinosporamide.
This two-step reaction pathway is consistent with a mechanism for partially
reversible proteasome inhibition by fluorosalinosporamide. Proteasome catalyzed
fluoride displacement provides preliminary insights into the active site Thr1N
pK(a).
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.C.Potts,
and
K.S.Lam
(2010).
Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.
|
| |
Mar Drugs,
8,
835-880.
|
 |
|
|
|
|
 |
T.A.Gulder,
and
B.S.Moore
(2010).
Salinosporamide natural products: potent 20 s proteasome inhibitors as promising cancer chemotherapeutics.
|
| |
Angew Chem Int Ed Engl,
49,
9346-9367.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
| | |